Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Insider Screener

Real-time Form 4 Filtering Engine

1. Asset & Type

2. Ranges (Min - Max)

3. Insider & Conviction

4. Company & Sector (SEC classification)

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry (by SEC) Type Price Qty Total, $ Owned After Change, %
2005-12-22 02:21 2005-12-20 ASTM Vericel Corp FINGERLE LINDA M Other Biological Products, (No Diagnostic Substances) SALE $2.32 21,000 $48,720 6,927 -75.2%
2005-08-19 23:40 2005-08-17 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.79 358 $999 7,927 +4.7%
2005-07-22 20:53 2005-07-20 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $3.12 320 $998 7,568 +4.4%
2005-06-22 23:06 2005-06-22 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.82 354 $998 7,248 +5.1%
2005-05-20 21:10 2005-05-18 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.00 498 $996 6,893 +7.8%
2005-04-22 20:56 2005-04-20 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.23 448 $999 6,394 +7.5%
2005-03-18 23:08 2005-03-16 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.64 379 $1,001 5,946 +6.8%
2005-02-19 00:29 2005-02-16 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.81 356 $1,000 5,566 +6.8%
2005-01-22 00:34 2005-01-19 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $2.60 96 $250 5,210 +1.9%
2004-12-23 23:35 2004-12-22 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $1.10 227 $250 5,114 +4.6%
2004-11-19 23:22 2004-11-17 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.95 262 $249 4,887 +5.7%
2004-10-22 21:32 2004-10-20 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $1.02 243 $248 4,625 +5.5%
2004-09-24 20:48 2004-09-22 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.89 564 $502 4,380 +14.8%
2004-08-24 23:46 2004-08-18 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.69 723 $499 3,816 +23.4%
2004-07-23 23:15 2004-07-21 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.87 575 $500 3,093 +22.8%
2004-06-18 22:49 2004-06-16 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.99 507 $502 2,518 +25.2%
2004-05-24 23:43 2004-05-24 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $0.88 570 $502 2,011 +39.6%
2004-05-17 22:25 2004-04-21 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $1.13 441 $498 1,441 +44.1%
2004-04-23 19:15 2004-04-21 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $1.13 385 $435 1,385 +38.5%
2004-03-04 19:11 2004-03-03 VCEL Vericel Corp FINGERLE LINDA M Director Biological Products, (No Diagnostic Substances) BUY $1.54 1,000 $1,540 1,000 +100.0%
SHOW ENTRIES

Strategic Signal Filtering

Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.

Investing Without Illusions

Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.